siRNAgen Therapeutics is a next-generation RNAi platform products company focused on immunology and central nervous system (CNS) diseases. Their proprietary SAMiRNA™ platform leverages modular chemistry to overcome the challenges around delivery. SAMiRNA™ platform has been instrumental in the creation of innovative drugs such as SRN-001, which holds immense promise in treating fibrotic diseases globally. With a firm commitment to innovation and collaboration, siRNAgen continues to push the boundaries of scientific discovery to change the lives of patients worldwide.
Company Details
- Employees
- 6
- Founded
- -
- Address
- 1 Broadway, Cambridge,massachusetts 02142,united States
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- https://www.sirnagen.com
- Keywords
- biotech, startup, RNAi platform, fibrosis, pharmaceutical, dermatology, oncology, CNS, clinical stage, seed stage.
- HQ
- Cambridge, Massachusetts
Sirnagen Therapeutics Questions
Sirnagen Therapeutics's website is https://www.sirnagen.com
Sirnagen Therapeutics's LinkedIn profile is https://www.linkedin.com/company/sirnagen-therapeutics
Sirnagen Therapeutics has
6 employees.
View email and phone details for 6
employees at Sirnagen Therapeutics.
Sirnagen Therapeutics's industry is
Pharmaceutical Manufacturing
Sirnagen Therapeutics's top competitors are
Stealth Biotech,
Cenos Therapeutics,
Beam Therapeutics,
Bioneer,
Onegene Biotechnology,
Aligos Therapeutics,
Nucyrna Therapeutics,
Termeer Institute,
Cosmerna_official,
Probably Genetic.
Sirnagen Therapeutics's categories are Pharmaceutical Manufacturing
Sirnagen Therapeutics's founding year is 2019
